Rein Therapeutics (RNTX) Cash from Investing Activities (2016 - 2023)
Rein Therapeutics (RNTX) reported Cash from Investing Activities of -$96,000 for Q4 2023, compared with $4.76 million a year earlier.
Analysis
Rein Therapeutics (RNTX) Cash from Investing Activities (2016 - 2023) Analysis & Trends
For FY2023, Rein Therapeutics posted Cash from Investing Activities of $16.2 million, down 38.8% from FY2022.
- Cash from Investing Activities has a five-year compound annual growth rate of -8.1% (FY2018 to FY2023).
- By year, Cash from Investing Activities came in at $26.46 million in FY2022, -$35.92 million in FY2021, $6.41 million in FY2020 and -$2.81 million in FY2019.
- The Q4 2023 figure ranks as the lowest quarterly Cash from Investing Activities since Q2 2021.
- Year over year, Cash from Investing Activities gained in three of the last five quarters, with growth averaging 6.8%.
- The high point for year-over-year Cash from Investing Activities in five years was Q1 2019 (growth of 232.2%); the low point was Q3 2023 (a decline of 87.0%).
- Per Business Quant data, the three quarters before Q4 2023 came in at $542,000 (Q3 2023), $8.5 million (Q2 2023) and $7.25 million (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Rein Therapeutics | 53.67 Mn | 53.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -96,000.00 |
| Sep 30, 2023 | 542,000.00 |
| Jun 30, 2023 | 8.50 Mn |
| Mar 31, 2023 | 7.25 Mn |
| Dec 31, 2022 | 4.76 Mn |
| Sep 30, 2022 | 4.18 Mn |
| Jun 30, 2022 | 5.86 Mn |
| Mar 31, 2022 | 11.65 Mn |
| Dec 31, 2021 | 2.25 Mn |
| Sep 30, 2021 | 4.09 Mn |
| Jun 30, 2021 | -4.80 Mn |
| Mar 31, 2021 | -37.46 Mn |
| Dec 31, 2020 | -357,000.00 |
| Sep 30, 2020 | -4.53 Mn |
| Jun 30, 2020 | 239,000.00 |
| Mar 31, 2020 | 11.06 Mn |
| Dec 31, 2019 | 4.76 Mn |
| Sep 30, 2019 | 3.74 Mn |
| Jun 30, 2019 | -19.29 Mn |
| Mar 31, 2019 | 7.97 Mn |
API Access
Rein Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RNTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();